Evotec (OTCMKTS:EVTCY) Reaches New 1-Year Low at $11.78

Evotec SE (OTCMKTS:EVTCYGet Rating) reached a new 52-week low during trading on Thursday . The stock traded as low as $11.78 and last traded at $11.88, with a volume of 41835 shares changing hands. The stock had previously closed at $12.24.

The company’s fifty day moving average is $13.28 and its 200 day moving average is $16.83. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The stock has a market cap of $3.92 billion, a PE ratio of 57.20 and a beta of 0.98.

About Evotec (OTCMKTS:EVTCY)

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.

Recommended Stories

Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.